Corporate/Financial News monkeypox Government and Military Security and asset marking COVID-19 Printing and Packaging Pharmaceuticals Personal care
U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract
July 18, 2024
APDN, Alphazyme Conclude Linea™ RNAP Manufacturing Scale-Up Project, Deliver Substantial Improvement in Linea™ IVT Platform Economics
June 20, 2024
APDN Partners with GenXys to Deploy Clinical Decision Support System for PGx Testing
June 18, 2024
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea™ IVT Platform
June 5, 2024
Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of APDN’s Linea DNA™ for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML
May 13, 2024
Get Social